Newsroom

Dr. Natalie Uy, a leading pediatric nephrologist, has been named chief of the Division of Pediatric Nephrology in the Department of Pediatrics at Weill Cornell Medicine and NewYork-Presbyterian Komansky Children’s Hospital, effective April 17.

The Division of Pediatric Nephrology provides compassionate care for newborns, children and young adults with complex kidney diseases and urologic conditions. Services provided include dialysis and kidney transplantation for patients with end-stage kidney disease.

Dr. Uy was recruited to Weill Cornell Medicine as an assistant professor of pediatrics from NewYork-Presbyterian/Columbia University Irving Medical Center. She previously served as director of the pediatric nephrology fellowship program and residency elective at NewYork-Presbyterian Morgan Stanley Children’s Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She succeeds Dr. Eduardo Perelstein, who led the division from 2014-2022 and remains on Weill Cornell Medicine’s voluntary faculty as a clinical associate professor of pediatrics.

Dr. Uy’s research focuses on the genetic causes of dysfunctional kidney filtering that results in excess protein and red blood cells in urine and a buildup of toxins in the blood, called glomerular disease.

“We are so fortunate to welcome Dr. Uy as our new chief of pediatric nephrology with her expertise and leadership in this highly specialized, and critical field in child health,” said Dr. Sallie Permar, chair of the Department of Pediatrics at Weill Cornell Medicine and pediatrician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center and NewYork-Presbyterian Komansky Children’s Hospital. “It is an important time for the field of pediatric nephrology given the nationwide shortage of trained pediatric nephrologists. I look forward to working with Dr. Uy as we grow and integrate programs and services for infants and children with challenging kidney and urologic diseases across our institutions, and work nationally and locally to attract and retain the best and brightest to this field to best serve children who need their services.”

“I’m very excited to take on this new role,” Dr. Uy said. “There is a big opportunity to expand the program for infants and children, especially treatment for pediatric end-stage kidney disease, including dialysis capabilities for the smallest patients in the intensive care unit and kidney transplantation. Integrating programs and services across institutions is essential for smaller sub-specialties like pediatric nephrology.”

As chief, Dr. Uy will lead a skilled team of pediatric nephrologists to enhance the division’s clinical programs and will work closely with research faculty who strive to expand the understanding of renal disorders in children and adolescents. She will work alongside a multidisciplinary team to provide high-quality medical care for children with acute and chronic kidney disease. She will create a new strategic plan to continue building and integrating pediatric nephrology care services at NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian Brooklyn Methodist Hospital and NewYork-Presbyterian Queens. Dr. Uy will further develop collaborations between colleagues in the divisions of Transplant Surgery, Adult Nephrology and Pediatric Urology at Weill Cornell Medicine, NewYork-Presbyterian/Columbia University Irving Medical Center and the Rogosin Institute, an organization that provides inpatient and outpatient dialysis services at NewYork-Presbyterian and other hospitals throughout New York City. Her goal is to grow the division to an even higher level of excellence, including the pediatric renal transplant and dialysis programs, which would allow dialysis treatment to even the smallest infants.

“The most common causes of end-stage kidney disease in pediatric patients are congenital anomalies of the kidney and urinary tract,” Dr. Uy said. “Through additional clinical services, we will be able to offer genetic testing more easily to diagnose hereditary kidney disease risk sooner and improve patients’ outcomes.”

About Dr. Natalie Uy

Dr. Uy received her undergraduate degree at Columbia University and her medical degree from Rutgers New Jersey Medical School. She completed an internship and a residency in pediatrics at Yale New Haven Children’s Hospital, followed by a fellowship in pediatric nephrology at the Children’s Hospital at Montefiore.

As a recognized specialist in pediatric nephrology, Dr. Uy has served as an expert for NewYork-Presbyterian’s Second Opinion program, which reviews complex cases and provides recommendations for patients across the country. As senior author of a paper published in Kidney360 in 2021, Dr. Uy was one of the first researchers worldwide to investigate the mechanisms underlying kidney injury in multisystem inflammatory syndrome in children, a rare condition associated with SARS-CoV-2 infection. She has also co-authored articles in other leading peer-reviewed journals, including the New England Journal of Medicine, the Journal of the American Society of Nephrology, Pediatric Nephrology and Pediatric Transplantation.

Dr. Uy has served as a training program director for the American Society of Pediatric Nephrology, and is a member of the American Society of Nephrology and Kidney and Urology Foundation of America. As invited faculty, she has delivered numerous talks on pediatric glomerular disease throughout the country. She has extensive experience training the next generation of pediatric nephrologists, and has served as a mentor to numerous residents, fellows and junior faculty members.

Weill Cornell Medicine

Weill Cornell Medicine is committed to excellence in patient care, scientific discovery and the education of future physicians in New York City and around the world. The doctors and scientists of Weill Cornell Medicine — faculty from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences, and Weill Cornell Physician Organization — are engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Located in the heart of the Upper East Side’s scientific corridor, Weill Cornell Medicine’s powerful network of collaborators extends to its parent university Cornell University; to Qatar, where Weill Cornell Medicine-Qatar offers a Cornell University medical degree; and to programs in Tanzania, Haiti, Brazil, Austria and Turkey. Weill Cornell Medicine faculty provide exemplary patient care at NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian Westchester Behavioral Health Center, NewYork-Presbyterian Lower Manhattan Hospital, NewYork-Presbyterian Queens and NewYork-Presbyterian Brooklyn Methodist Hospital. Weill Cornell Medicine is also affiliated with Houston Methodist. For more information, visit weill.cornell.edu.

NewYork-Presbyterian

NewYork-Presbyterian is one of the nation’s most comprehensive, integrated academic healthcare systems, encompassing 10 hospitals across the Greater New York area, nearly 200 primary and specialty care clinics and medical groups, and an array of telemedicine services.

A leader in medical education, NewYork-Presbyterian Hospital is the only academic medical center in the nation affiliated with two world-class medical schools, Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons. This collaboration means patients have access to the country’s leading physicians, the full range of medical specialties, latest innovations in care, and research that is developing cures and saving lives.

Founded 250 years ago, NewYork-Presbyterian Hospital has a long legacy of medical breakthroughs and innovation, from the invention of the Pap test to pioneering the groundbreaking heart valve replacement procedure called TAVR.

NewYork-Presbyterian’s 48,000 employees and affiliated physicians are dedicated to providing the highest quality, most compassionate care to New Yorkers and patients from across the country and around the world.

For more information, visit www.nyp.org and find us on Facebook, Twitter, Instagram, and YouTube.